H. Lin, A. Ho, and D. Haley-vicente, Cloning and Characterization of IL-1HY2, a Novel Interleukin-1 Family Member, Journal of Biological Chemistry, vol.161, issue.23, pp.20597-602, 2001.
DOI : 10.1074/jbc.270.23.13757

J. Mora, A. Schlemmer, and I. Wittig, Interleukin-38 is released from apoptotic cells to limit inflammatory macrophage responses, Journal of Molecular Cell Biology, vol.8, issue.5, pp.426-464, 2016.
DOI : 10.1093/jmcb/mjw006

M. Boutet, G. Bart, and M. Penhoat, , their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease, Clinical & Experimental Immunology, vol.1849, issue.2, pp.159-73, 2016.
DOI : 10.1016/j.bbagrm.2015.06.002
URL : http://onlinelibrary.wiley.com/doi/10.1111/cei.12761/pdf

C. Chou, A. Timms, and J. Wei, Replication of association of IL1 gene complex members with ankylosing spondylitis in Taiwanese Chinese, Annals of the Rheumatic Diseases, vol.65, issue.8, pp.1106-1115, 2006.
DOI : 10.1136/ard.2005.046847

M. Jung, S. Kang, and S. Kim, The interleukin-1 family gene polymorphisms in Korean patients with rheumatoid arthritis, Scandinavian Journal of Rheumatology, vol.115, issue.3, pp.190-196, 2010.
DOI : 10.3901/JME.2002.03.046

Z. Guo, C. Li, and Z. Lin, Association of IL-1 gene complex members with ankylosing spondylitis in Chinese Han population, International Journal of Immunogenetics, vol.41, issue.1, pp.33-40, 2010.
DOI : 10.1111/j.1744-313X.2009.00889.x

A. Dehghan, J. Dupuis, and M. Barbalic, Meta-Analysis of Genome-Wide Association Studies in >80 000 Subjects Identifies Multiple Loci for C-Reactive Protein Levels, Circulation, vol.123, issue.7, pp.731-739, 2011.
DOI : 10.1161/CIRCULATIONAHA.110.948570

P. Rahman, S. Sun, and L. Peddle, Association between the interleukin-1 family gene cluster and psoriatic arthritis, Arthritis & Rheumatism, vol.68, issue.7, pp.2321-2326, 2006.
DOI : 10.1002/art.21928
URL : http://onlinelibrary.wiley.com/doi/10.1002/art.21928/pdf

I. Rudloff, J. Godsell, and C. Nold-petry, Brief Report: Interleukin-38 Exerts Antiinflammatory Functions and Is Associated With Disease Activity in Systemic Lupus Erythematosus, Arthritis & Rheumatology, vol.71, issue.12, pp.3219-3244, 2015.
DOI : 10.1016/j.humimm.2010.06.004

H. Wang, Y. Jiang, and X. Wang, Elevated serum interleukin-38 level at baseline predicts virological response in telbivudine-treated patients with chronic hepatitis B, World Journal of Gastroenterology, vol.22, issue.18, pp.4529-4566, 2016.
DOI : 10.1371/journal.ppat.1003208

Y. Zhong, K. Yu, and X. Wang, Elevated Plasma IL-38 Concentrations in Patients with Acute ST-Segment Elevation Myocardial Infarction and Their Dynamics after Reperfusion Treatment, Mediators of Inflammation, vol.68, issue.6, p.490120, 2015.
DOI : 10.1161/01.CIR.96.3.778

M. Chu, I. Chu, and E. Yung, Aberrant Expression of Novel Cytokine IL-38 and Regulatory T Lymphocytes in Childhood Asthma, Molecules, vol.21, issue.7, p.933, 2016.
DOI : 10.1016/j.jaci.2012.06.025

M. Wang, B. Wang, and Z. Ma, Detection of the novel IL-1 family cytokines by QAH-IL1F-1 assay in rheumatoid arthritis, Cell Mol Biol, vol.62, pp.31-35, 2016.

S. Takenaka, S. Kaieda, and T. Kawayama, IL-38: A new factor in rheumatoid arthritis, Biochemistry and Biophysics Reports, vol.4, pp.386-91, 2015.
DOI : 10.1016/j.bbrep.2015.10.015

F. De-veerdonk, A. Stoeckman, and G. Wu, IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist, Proceedings of the National Academy of Sciences, vol.270, issue.19, pp.3001-3006, 2012.
DOI : 10.1074/jbc.270.19.11477

K. Payne, H. Lee, and A. Haleem, Single intra-articular injection of adeno-associated virus results in stable and controllable in vivo transgene expression in normal rat knees, Osteoarthritis and Cartilage, vol.19, issue.8, pp.1058-65, 2011.
DOI : 10.1016/j.joca.2011.04.009

P. Guihard, M. Boutet, and B. Brounais-le-royer, Oncostatin M, an Inflammatory Cytokine Produced by Macrophages, Supports Intramembranous Bone Healing in a Mouse Model of Tibia Injury, The American Journal of Pathology, vol.185, issue.3, pp.765-75, 2015.
DOI : 10.1016/j.ajpath.2014.11.008

B. Goff, E. Soltner, and C. Charrier, A combination of methotrexate and zoledronic acid prevents bone erosions and systemic bone mass loss in collagen induced arthritis, Arthritis Research & Therapy, vol.11, issue.6, p.185, 2009.
DOI : 10.1186/ar2877
URL : https://hal.archives-ouvertes.fr/inserm-00663553

P. Guihard, Y. Danger, and B. Brounais, Induction of Osteogenesis in Mesenchymal Stem Cells by Activated Monocytes/Macrophages Depends on Oncostatin M Signaling, STEM CELLS, vol.74, issue.4, pp.762-72, 2012.
DOI : 10.1086/381715
URL : https://hal.archives-ouvertes.fr/inserm-00668995

E. David, F. Tirode, and M. Baud-'huin, Oncostatin M Is a Growth Factor for Ewing Sarcoma, The American Journal of Pathology, vol.181, issue.5, pp.1782-95, 2012.
DOI : 10.1016/j.ajpath.2012.07.023

B. Brounais, E. David, and C. Chipoy, Long term oncostatin M treatment induces an osteocyte-like differentiation on osteosarcoma and calvaria cells, Bone, vol.44, issue.5, pp.830-839, 2009.
DOI : 10.1016/j.bone.2008.12.021

C. Zeng, W. Wang, and X. Yu, Pathways related to PMA-differentiated THP1 human monocytic leukemia cells revealed by RNA-Seq, Science China Life Sciences, vol.26, issue.12, pp.1282-1289, 2015.
DOI : 10.1016/j.leukres.2004.12.011
URL : https://link.springer.com/content/pdf/10.1007%2Fs11427-015-4967-4.pdf

F. Brentano, C. Ospelt, and J. Stanczyk, Abundant expression of the interleukin (IL)23 subunit p19, but low levels of bioactive IL23 in the rheumatoid synovium: differential expression and Toll-like receptor-(TLR) dependent regulation of the IL23 subunits, p19 and p40, in rheumatoid arthritis, Annals of the Rheumatic Diseases, vol.68, issue.1, pp.143-50, 2009.
DOI : 10.1136/ard.2007.082081

C. Gabay, L. Marinova-mutafchieva, and R. Williams, Increased production of intracellular interleukin-1 receptor antagonist type I in the synovium of mice with collagen-induced arthritis: A possible role in the resolution of arthritis, Arthritis & Rheumatism, vol.155, issue.2, pp.451-62, 2001.
DOI : 10.1002/1529-0131(200102)44:2<451::AID-ANR64>3.0.CO;2-H

G. Schett, D. Elewaut, and I. Mcinnes, How Cytokine Networks Fuel Inflammation: Toward a cytokine-based disease taxonomy, Nature Medicine, vol.19, issue.7, pp.822-826, 2013.
DOI : 10.1038/nm.2635

R. Onishi and S. Gaffen, Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease, Immunology, vol.182, issue.3, pp.311-332, 2010.
DOI : 10.4049/jimmunol.179.6.4135

M. Scheibel, B. Klein, and H. Merkle, I??B?? is an essential co-activator for LPS-induced IL-1?? transcription in vivo, The Journal of Experimental Medicine, vol.150, issue.12, pp.2621-2651, 2010.
DOI : 10.1038/nature02738

P. Ruscitti, P. Cipriani, and F. Carubbi, The role of IL-1? in the bone loss during rheumatic diseases, Mediators Inflamm, vol.2015, p.782382, 2015.

M. Hong, H. Williams, and C. Jin, The Inhibitory Effect of Interleukin-10 on Mouse Osteoclast Formation Involves Novel Tyrosine-Phosphorylated Proteins, Journal of Bone and Mineral Research, vol.137, issue.5, pp.911-929, 2000.
DOI : 10.1128/MCB.19.5.3485

A. Korganow, H. Ji, and S. Mangialaio, From Systemic T Cell Self-Reactivity to Organ-Specific Autoimmune Disease via Immunoglobulins, Immunity, vol.10, issue.4, pp.451-61, 1999.
DOI : 10.1016/S1074-7613(00)80045-X
URL : https://doi.org/10.1016/s1074-7613(00)80045-x

P. Wong, J. Quinn, and N. Sims, Interleukin-6 modulates production of T lymphocyte???derived cytokines in antigen-induced arthritis and drives inflammation-induced osteoclastogenesis, Arthritis & Rheumatism, vol.161, issue.1, pp.158-68, 2006.
DOI : 10.4049/jimmunol.166.9.5327

P. Wooley, J. Whalen, and D. Chapman, The effect of an interleukin-1 receptor antagonist protein on type ii collagen???induced arthritis and antigen-induced arthritis in mice, Arthritis & Rheumatism, vol.33, issue.9, pp.1305-1319, 1993.
DOI : 10.1042/cs0760535

J. Towne, B. Renshaw, and J. Douangpanya, Interleukin-36 (IL-36) Ligands Require Processing for Full Agonist (IL-36??, IL-36??, and IL-36??) or Antagonist (IL-36Ra) Activity, Journal of Biological Chemistry, vol.167, issue.49, pp.42594-602, 2011.
DOI : 10.1056/NEJMoa1013068
URL : http://www.jbc.org/content/286/49/42594.full.pdf